"Leiomyosarcoma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A sarcoma containing large spindle cells of smooth muscle. Although it rarely occurs in soft tissue, it is common in the viscera. It is the most common soft tissue sarcoma of the gastrointestinal tract and uterus. The median age of patients is 60 years. (From Dorland, 27th ed; Holland et al., Cancer Medicine, 3d ed, p1865)
Descriptor ID |
D007890
|
MeSH Number(s) |
C04.557.450.590.455 C04.557.450.795.455
|
Concept/Terms |
Leiomyosarcoma, Epithelioid- Leiomyosarcoma, Epithelioid
- Epithelioid Leiomyosarcoma
- Epithelioid Leiomyosarcomas
- Leiomyosarcomas, Epithelioid
Leiomyosarcoma, Myxoid- Leiomyosarcoma, Myxoid
- Leiomyosarcomas, Myxoid
- Myxoid Leiomyosarcoma
- Myxoid Leiomyosarcomas
|
Below are MeSH descriptors whose meaning is more general than "Leiomyosarcoma".
Below are MeSH descriptors whose meaning is more specific than "Leiomyosarcoma".
This graph shows the total number of publications written about "Leiomyosarcoma" by people in this website by year, and whether "Leiomyosarcoma" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 3 | 0 | 3 |
1995 | 2 | 0 | 2 |
1996 | 2 | 1 | 3 |
1997 | 2 | 1 | 3 |
1998 | 1 | 1 | 2 |
1999 | 4 | 1 | 5 |
2000 | 3 | 1 | 4 |
2001 | 1 | 1 | 2 |
2002 | 4 | 0 | 4 |
2003 | 3 | 4 | 7 |
2004 | 4 | 1 | 5 |
2005 | 2 | 0 | 2 |
2006 | 2 | 1 | 3 |
2007 | 6 | 2 | 8 |
2008 | 2 | 2 | 4 |
2009 | 3 | 3 | 6 |
2010 | 8 | 2 | 10 |
2011 | 3 | 0 | 3 |
2012 | 6 | 2 | 8 |
2013 | 4 | 1 | 5 |
2014 | 0 | 1 | 1 |
2015 | 5 | 1 | 6 |
2016 | 4 | 1 | 5 |
2017 | 3 | 0 | 3 |
2018 | 1 | 0 | 1 |
2019 | 2 | 0 | 2 |
2020 | 1 | 1 | 2 |
2021 | 3 | 0 | 3 |
2022 | 1 | 0 | 1 |
2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Leiomyosarcoma" by people in Profiles.
-
Phase I Study of mTORC1/2 Inhibitor Sapanisertib (CB-228/TAK-228) in Combination with Metformin in Patients with mTOR/AKT/PI3K Pathway Alterations and Advanced Solid Malignancies. Cancer Res Commun. 2024 02 12; 4(2):378-387.
-
Integrative Genomic and Transcriptomic Profiling Reveals a Differential Molecular Signature in Uterine Leiomyoma versus Leiomyosarcoma. Int J Mol Sci. 2022 Feb 16; 23(4).
-
Current update on IVC leiomyosarcoma. Abdom Radiol (NY). 2021 11; 46(11):5284-5296.
-
Second Malignancies after Radiation Therapy: Update on Pathogenesis and Cross-sectional Imaging Findings. Radiographics. 2021 May-Jun; 41(3):876-894.
-
Relationships between highly recurrent tumor suppressor alterations in 489 leiomyosarcomas. Cancer. 2021 08 01; 127(15):2666-2673.
-
Differences in gynecologic tumor development in Amhr2-Cre mice with KRASG12D or KRASG12V mutations. Sci Rep. 2020 11 26; 10(1):20678.
-
Characterizing the efficacy and trends of adjuvant therapy versus observation in women with early stage (uterine confined) leiomyosarcoma: a National Cancer Database study. J Gynecol Oncol. 2020 May; 31(3):e21.
-
Safety and efficacy of trabectedin when administered in the inpatient versus outpatient setting: Clinical considerations for outpatient administration of trabectedin. Cancer. 2019 Dec 15; 125(24):4435-4441.
-
Overall survival and histology-specific subgroup analyses from a phase 3, randomized controlled study of trabectedin or dacarbazine in patients with advanced liposarcoma or leiomyosarcoma. Cancer. 2019 08 01; 125(15):2610-2620.
-
Resection of a Perirectal Leiomyosarcoma via a Posterior Transcoccygeal Approach. Ann Surg Oncol. 2018 Sep; 25(9):2641.